Cure My Disease

Don't miss your cure!

 Log in / Sign up

New sponge could speed up bleeding control after wisdom tooth extraction

NCT ID NCT07179523

Disease control Sponsor: Sara Omar Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-phase trial tested a special sponge called ColiSorB to see how well it stops bleeding after a molar (back tooth) is removed. The study included 30 people who needed a wisdom tooth taken out. The sponge is designed to absorb blood and help the body's natural clotting process. Researchers measured how fast bleeding stopped and how comfortable patients felt afterward.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ColiSorB hemostatic sponge
What this could lead to
If it works, this could offer a faster, more effective way to control bleeding after tooth removal, improving patient comfort and healing.
What could go wrong
This is a very early, small trial (30 people) testing a device for a routine procedure. The results may not apply to everyone, and the sponge may not work better than standard gauze.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Early phase 1

The earliest testing in people: a first look at safety, in a very small group.

Participants

30 people

The number who actually took part.

Started

Sep 2023

Finished

Oct 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

14 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria * Patients seeking removal of a wisdom tooth due to: * Severe decay * Malposition/misalignment * Pressure caries affecting adjacent teeth * Indication for future orthodontic treatment * Age ≥ 14 years * Available for at least one postoperative evaluation (scheduled approximately 7 days post-surgery) * Willing and able to provide informed consent for participation Exclusion Criteria * Unwillingness to provide informed consent * Current use of anticoagulant medications (e.g., Aspirin, Coumadin, Plavix) or discontinuation of such medications \< 3 days prior to surgery * Pregnant, planning pregnancy during the follow-up period, or actively breastfeeding * Active or suspected infection at the surgical site * Known sensitivity or allergy to any component of the hemostatic gelatin sponge * Severe congenital or acquired immunodeficiency * Undergoing bisphosphonate therapy * Diabetes with unstable blood glucose levels

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Molar extraction socket are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Molar extraction socket

Contacts and locations

Locations

  • Department of Oral & maxillofacial surgery at Cairo University

    Cairo, Giza Governorate, 12613, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.